• Fri, June 4, 2021

by: WOPRAI

Ben Bienvenu Maintained (CASY) at Buy with Increased Target to $250 on, Jun 4th, 2021

by: WOPRAI

Nicole Deblase Maintained (CAT) at Strong Buy with Increased Target to $273 on, Jun 4th, 2021

by: WOPRAI

Michael Goldsmith Initiated (SPG) at Hold and Held Target at $135 on, Jun 4th, 2021

by: WOPRAI

Andrew Fein Initiated (CCCC) at Strong Buy and Held Target at $63 on, Jun 4th, 2021

by: WOPRAI

Glenn Schorr Maintained (TROW) at Buy and Held Target at $200 on, Jun 4th, 2021

by: WOPRAI

RJ Milligan Maintained (VICI) at Strong Buy with Increased Target to $36 on, Jun 4th, 2021

by: WOPRAI

Michael Rose Maintained (VBTX) at Strong Buy with Increased Target to $42 on, Jun 4th, 2021

by: WOPRAI

Michael Pachter Maintained (AMC) at Hold with Increased Target to $66 on, Jun 4th, 2021

by: WOPRAI

Joshua Jennings Maintained (ABT) at Buy with Decreased Target to $125 on, Jun 4th, 2021

by: WOPRAI

Joshua Pokrzywinski Maintained (SWIM) at Hold with Decreased Target to $32 on, Jun 4th, 2021

by: WOPRAI

Michael Goldsmith Initiated (SUI) at Strong Buy and Held Target at $190 on, Jun 4th, 2021

by: WOPRAI

David Chiaverini Initiated (BUR) at Buy and Held Target at $15 on, Jun 4th, 2021

by: WOPRAI

David Begleiter Maintained (WLK) at Hold with Increased Target to $112 on, Jun 4th, 2021

by: WOPRAI

Jeffrey Osborne Downgraded (WKHS) to Hold and Held Target at $260 on, Jun 4th, 2021

by: WOPRAI

Leland Gershell Initiated (WINT) at Buy on, Jun 4th, 2021

by: WOPRAI

Erika Najarian Upgraded (WFC) to Strong Buy and Held Target at $60 on, Jun 4th, 2021

by: WOPRAI

Matt Koranda Maintained (TLYS) at Strong Buy with Increased Target to $20 on, Jun 4th, 2021

by: WOPRAI

Andreas Bokkenheuser Upgraded (X) to Hold and Increased Target to $30 on, Jun 4th, 2021

by: WOPRAI

Michael Lewis Maintained (UDR) at Hold with Increased Target to $52 on, Jun 4th, 2021

by: WOPRAI

Felix Boeschen Maintained (UPS) at Strong Buy with Increased Target to $240 on, Jun 4th, 2021

by: WOPRAI

Kimberly Greenberger Maintained (ANF) at Sell with Increased Target to $31 on, Jun 4th, 2021

by: WOPRAI

Bill Carcache Maintained (AXP) at Buy with Increased Target to $197 on, Jun 4th, 2021

by: WOPRAI

Andrew Berens Maintained (AZN) at Buy with Increased Target to $64 on, Jun 4th, 2021

by: WOPRAI

Matthew Sykes Initiated (TWST) at Hold and Held Target at $110 on, Jun 4th, 2021

by: WOPRAI

Matthew Sykes Initiated (AVTR) at Strong Buy and Held Target at $40 on, Jun 4th, 2021

by: WOPRAI

Weston Twigg Maintained (AVGO) at Buy with Increased Target to $57 on, Jun 4th, 2021

by: WOPRAI

Blayne Curtis Maintained (AVGO) at Buy with Increased Target to $53 on, Jun 4th, 2021

by: WOPRAI

Aaron Rakers Maintained (AVGO) at Hold with Increased Target to $48 on, Jun 4th, 2021

by: WOPRAI

Hans Mosesmann Maintained (AVGO) at Strong Buy with Increased Target to $55 on, Jun 4th, 2021

by: WOPRAI

Craig Hettenbach Maintained (AVGO) at Buy with Increased Target to $56 on, Jun 4th, 2021

by: WOPRAI

Vijay Rakesh Maintained (AVGO) at Strong Buy with Increased Target to $52 on, Jun 4th, 2021

by: WOPRAI

Ross Seymore Maintained (AVGO) at Strong Buy with Increased Target to $53 on, Jun 4th, 2021

by: WOPRAI

Christopher Danely Maintained (AVGO) at Strong Buy with Increased Target to $53 on, Jun 4th, 2021

by: WOPRAI

Michael Lewis Downgraded (AVB) to Hold on, Jun 4th, 2021

by: WOPRAI

Andrew Fein Initiated (TARA) at Strong Buy and Held Target at $40 on, Jun 4th, 2021

by: WOPRAI

Scott Group Downgraded (ARCB) to Hold on, Jun 4th, 2021

by: WOPRAI

Anthony Powell Maintained (APLE) at Hold with Increased Target to $17 on, Jun 4th, 2021

by: WOPRAI

Steve Enders Maintained (ASAN) at Buy with Increased Target to $48 on, Jun 4th, 2021

by: WOPRAI

Brent Bracelin Maintained (ASAN) at Buy with Increased Target to $52 on, Jun 4th, 2021

by: WOPRAI

Patrick Walravens Maintained (ASAN) at Buy with Increased Target to $50 on, Jun 4th, 2021

by: WOPRAI

Matthew Hedberg Maintained (ASAN) at Buy with Increased Target to $45 on, Jun 4th, 2021

by: WOPRAI

Stan Zlotsky Maintained (ASAN) at Hold with Increased Target to $37 on, Jun 4th, 2021

by: WOPRAI

Jared Shaw Downgraded (ASB) to Hold and Held Target at $24 on, Jun 4th, 2021

  • Mon, June 7, 2021

by: WOPRAI

Jordan Alliger Downgraded (ARCB) to Hold and Decreased Target to $71 on, Jun 7th, 2021

by: WOPRAI

Devin McDermott Upgraded (TELL) to Hold and Held Target at $8 on, Jun 7th, 2021

by: WOPRAI

Bose George Downgraded (AGNC) to Hold and Held Target at $18 on, Jun 7th, 2021

by: WOPRAI

Tristan Gerra Maintained (AVGO) at Buy with Increased Target to $55 on, Jun 7th, 2021

by: WOPRAI

Jordan Alliger Downgraded (WERN) to Strong Sell and Held Target at $45 on, Jun 7th, 2021

Andrew Fein Initiated (CCCC) at Strong Buy and Held Target at $63 on, Jun 4th, 2021

Andrew Fein of HC Wainwright & Co., Initiated "C4 Therapeutics, Inc." (CCCC) at Strong Buy and Held Target at $63 on, Jun 4th, 2021.

Andrew has made no other calls on CCCC in the last 4 months.



There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew

  • Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $55 on, Wednesday, March 31st, 2021

Like: 👍